Sandoz Rolls Out Natalizumab Biosimilar In Germany

Tyruko Version Of Natalizumab Will Rival Biogen’s Tysabri In A Major EU Market

 
• By David Wallace
  
German flag in paint stripes
Sandoz is launching natalizumab in Germany • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Products

More from Generics Bulletin